FDA — authorised 21 January 2021
- Application: NDA212888
- Marketing authorisation holder: VIIV HLTHCARE
- Local brand name: CABENUVA KIT
- Indication: SUSPENSION, EXTENDED RELEASE — INTRAMUSCULAR
- Status: approved
🇺🇸 Vocabria in United States
FDA authorised Vocabria on 21 January 2021
Marketing authorisations
FDA
- Status: approved
Vocabria in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Vocabria approved in United States?
Yes. FDA authorised it on 21 January 2021; FDA has authorised it.
Who is the marketing authorisation holder for Vocabria in United States?
VIIV HLTHCARE holds the US marketing authorisation.